Skip to Main Content

The virtual care company Onduo is widening its reach: On Tuesday, the Alphabet-owned company announced it was bringing its chronic disease management platform to patients with certain cardiometabolic conditions, including hypertension and prediabetes.

The move marks a significant expansion of the mission of the company, which was spun out of Alphabet’s life science unit Verily and initially targeted patients with type 2 diabetes. But it’s not the only change aimed at broadening the company’s user base: Onduo will also start providing its services in Spanish.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!